Petros Pharmaceuticals, Inc. Other Current Liabilities
Petros Pharmaceuticals, Inc. (PTPI) had Other Current Liabilities of $78.17 thousand as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2025-03-31
- 2024-12-31: Other Liabilities, Current $78.17K.
- 2024-09-30: Other Liabilities, Current $352.77K.
- 2024-06-30: Other Liabilities, Current $350.54K.
- 2024-03-31: Other Liabilities, Current $362.23K.
| Period end | Other Liabilities, Current |
|---|---|
| 2024-12-31 | $78.17K 10-K · filed 2025-03-31 |
| 2024-09-30 | $352.77K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $350.54K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $362.23K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $493.29K 10-K · filed 2025-03-31 |
| 2023-09-30 | $349.97K 10-Q · filed 2023-11-15 |
| 2023-06-30 | $280.45K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $311.98K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $537.23K 10-K · filed 2024-04-01 |
| 2022-09-30 | $471.48K 10-Q/A · filed 2022-11-15 |
| 2022-06-30 | $559.53K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $352.44K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $260.82K 10-K · filed 2023-03-31 |
| 2021-09-30 | $649.47K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $497.92K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $296.62K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $221.77K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |